Westwicke to Sponsor Consilium Strategic Communications’ Annual Healthcare Conference
Baltimore, Md. October 31, 2017 – Westwicke, the largest independent healthcare-focused investor relations and capital markets advisory firm in the U.S, will join its partner, Consilium Strategic Communications, a global leader in strategic healthcare communications, as a cosponsor of Consilium’s Annual Healthcare Conference on November 14 along with Cooley and RBC Capital Markets.
The annual conference is an invitation-only gathering of leading experts in the healthcare communications and investor relations professions. Attendees will network and participate in panel discussions on topics vital to our industry. This year’s event, in London, will include panels on topics such as:
- Accessing Foreign Capital
- Investing in Diagnosis for Patients and Profitability
- The Current M&A Environment
- The Politics of Healthcare
“The equity markets have been roaring throughout the year, despite political upheaval in advanced democracies around the world, including the United States and Great Britain,” said Tom McDonald, Managing Director of Westwicke. “The Annual Healthcare Conference is a wonderful opportunity for leaders to gather in an intimate setting to discuss the impact of events on our industry and the overall direction of the healthcare equity markets.”
The conference will take place from 12:00 p.m. to 6:30 p.m. GMT on November 14 at Etc. Venues, 8 Eastcheap, London. Find out more and make your plans.
Westwicke provides customized strategic investor relations programs and independent capital markets advice to public and private healthcare companies. Westwicke focuses on the healthcare sector exclusively, and is headquartered in Baltimore with regional offices in Boston, New York, San Diego, and San Francisco. For more information, please visit www.westwickepartners.com.
About Consilium Strategic Communications
Consilium Strategic Communications is a global leader in strategic healthcare communications advisory with offices in London and across the U.S. Consilium’s highly-skilled team provides strategic, long-term advice to healthcare companies, Boards, senior decision makers and executives on critical communications programs and stakeholder challenges. The Company has established deep knowledge across all areas of the global healthcare sector through broad experience in representing international clients spanning the Fortune 500, FTSE100, FTSEurofirst 300 and FTSE250, through to discrete specialist reputation management projects. For more information, please visit www.consilium-comms.com.
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law. Cooley has 900 lawyers across 12 offices in the United States, China and Europe. For more information, please visit www.cooley.com.
About RBC Capital Markets
RBC Capital Markets is a premier global investment bank providing expertise in banking, finance and capital markets to corporations, institutional investors, asset managers and governments around the world. We serve clients from 70 offices in 15 countries across North America, the UK, Europe and the Asia-Pacific region. Our more than 7,200 professionals deliver the experience and insights required to raise capital, access markets, mitigate risk and acquire or dispose of assets for clients worldwide. We are consistently ranked, by third-party sources, among the 10 largest and most significant investment banks globally.
RBC Capital Markets is part of a leading, diversified provider of financial services, Royal Bank of Canada (RBC). Operating since 1869, RBC is one of the largest banks in the world and the fifth largest in North America, as measured by market capitalization. With a strong capital base and consistent financial performance, RBC is among a small group of highly rated global banks. For more information, please visit www.rbccm.com.
Consilium Strategic Communications
Mary-Jane Elliott / Amber Fennell
+44 (0) 20 3709 5700
RBC Capital Markets
+44 (0) 20 7029 7845